HMOX1 silencing prevents doxorubicin-induced cardiomyocyte injury, mitochondrial dysfunction, and ferroptosis by downregulating CTGF
Crossref DOI link: https://doi.org/10.1007/s11748-022-01867-7
Published Online: 2022-08-25
Published Print: 2023-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Qian, Jia
Wan, Wenting
Fan, Min
Text and Data Mining valid from 2022-08-25
Version of Record valid from 2022-08-25
Article History
Received: 5 June 2022
Accepted: 14 August 2022
First Online: 25 August 2022
Declarations
:
: The authors report no relationships that could be construed as a conflict of interest.